These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20937322)

  • 21. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.
    de Melker HE; van den Hof S; Berbers GA; Conyn-van Spaendonck MA
    Vaccine; 2003 Jan; 21(7-8):716-20. PubMed ID: 12531347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active immunization of children with leukemia and other malignancies.
    Ridgway D; Wolff LJ
    Leuk Lymphoma; 1993 Feb; 9(3):177-92. PubMed ID: 8471977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
    Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
    Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Martinón-Torres F; Boisnard F; Thomas S; Sadorge C; Borrow R;
    Vaccine; 2017 Jun; 35(30):3764-3772. PubMed ID: 28583305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing childhood vaccination coverage of the refugee and migrant population in Greece through the European programme PHILOS, April 2017 to April 2018.
    Mellou K; Silvestros C; Saranti-Papasaranti E; Koustenis A; Pavlopoulou ID; Georgakopoulou T; Botsi C; Terzidis A
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic analysis of prevaccination serotesting compared with presumptive immunization for polio, diphtheria, and tetanus in internationally adopted and immigrant infants.
    Cohen AL; Veenstra D
    Pediatrics; 2006 May; 117(5):1650-5. PubMed ID: 16651319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Internationally adopted children: what vaccines should they receive?
    Cilleruelo MJ; de Ory F; Ruiz-Contreras J; González-González R; Mellado MJ; García-Hortelano M; Villota J; García-Ascaso M; Piñeiro R; Martín-Fontelos P; Herruzo R
    Vaccine; 2008 Oct; 26(46):5784-90. PubMed ID: 18786590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.
    Mansor-Lefebvre S; Le Strat Y; Bernadou A; Vignier N; Guthmann JP; Arnaud A; Lévy-Bruhl D; Vandentorren S
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326203
    [No Abstract]   [Full Text] [Related]  

  • 35. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventable diseases--United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(29):665-71. PubMed ID: 9237476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS].
    Feldblyum IV; Nikolaeva AM; Pavroz KA; Danilina TV; Sosnina OY; Vyaznikova TV; Ershov AE; Trofimov DM; Polushkina AV
    Zh Mikrobiol Epidemiol Immunobiol; 2016; (1):46-51. PubMed ID: 27029116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers.
    Lee AW; Jordanov E; Boisnard F; Marshall GS
    Expert Rev Vaccines; 2017 Feb; 16(2):85-92. PubMed ID: 27996332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.
    Verla-Tebit E; Zhu X; Holsinger E; Mandalakas AM
    Arch Pediatr Adolesc Med; 2009 May; 163(5):473-9. PubMed ID: 19414695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.